Idi: PLC acquires Creapharm Cosmetics
Published on 01/08/2024 at 12:23 pm GMT - Modified on 01/08/2024 at 12:28 pm GMT
Contact us to request a correction
This first structuring acquisition enables PLC to round out its product offering and consolidate its position as a benchmark player in the CDMO market for cosmetics and dietary supplement brands.
The group now has almost 80 employees and pro forma sales of over 22 million euros in 2023 (+38%). The Placet family, shareholders in Creapharm, will reinvest as minority shareholders in the new entity.
Copyright (c) 2024 CercleFinance.com. All rights reserved.

















